➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Mallinckrodt
McKesson
McKinsey
Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Drug Price Trends for MESALAMINE DR

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for MESALAMINE DR

Average Pharmacy Cost for MESALAMINE DR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MESALAMINE DR 400 MG CAPSULE 59762-0117-01 1.95725 EACH 2020-07-22
MESALAMINE DR 1.2 GM TABLET 00378-7401-78 3.43093 EACH 2020-07-22
MESALAMINE DR 1.2 GM TABLET 00591-2245-22 3.43093 EACH 2020-07-22
MESALAMINE DR 1.2 GM TABLET 54092-0100-01 3.43093 EACH 2020-07-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Merck
McKesson
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.